BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 178555)

  • 1. Cyclic nucleotides in pancreatic islets. Tolbutamide- and arginine-induced insulin release.
    Charles MA; Lawecki J; Steiner AL; Grodsky GM
    Diabetes; 1976 Apr; 25(4):256-9. PubMed ID: 178555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effect of exogenous insulin on insulin secretion. Studies with glucose, leucine, arginine, aminophylline and tolbutamide.
    Verspohl EJ; Händel M; Hagenloh I; Ammon HP
    Acta Diabetol Lat; 1982; 19(4):303-17. PubMed ID: 6758458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP and insulin release.
    Grill V
    Acta Paediatr Scand Suppl; 1977; (270):41-7. PubMed ID: 210617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
    Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
    Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mode of action of adenosine 3':5'-cyclic monophosphate in mammalian islets of Langerhans. Effects of insulin secretagogues on islet-cell protein kinase activity.
    Montague W; Howell SL
    Biochem J; 1973 May; 134(1):321-7. PubMed ID: 4353086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cyclic AMP and alloxan on insulin secretion in isolated rat islets perifused in vitro.
    Tomita T; Scarpelli DG
    Endocrinology; 1977 May; 100(5):1327-33. PubMed ID: 191240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tolbutamide on aminophylline-, 3,5-AMP-dibutyrate- or glucagon-induced insulin release from pancreatic islets after impairment of pyridine nucleotide metabolism caused by 6-aminonicotinamide (6-AN).
    Ammon HP
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):251-64. PubMed ID: 241943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of adenosine 3':5'-cyclic monophosphate in the regulation of insulin release. Properties of islet-cell adenosine 3':5'-cyclic monophosphate phosphodiesterase.
    Sams DJ; Montague W
    Biochem J; 1972 Oct; 129(4):945-52. PubMed ID: 4347900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of insulin secretion from isolated rat islets by SaRI 59-801. Relation to cAMP concentration and Ca2+ uptake.
    Hanson RL; Isaacson CM
    Diabetes; 1985 Jul; 34(7):691-5. PubMed ID: 2408949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the action of tolbutamide in normal man. 3. Interaction of tolbutamide with glucagon, aminophylline and arginine in stimulating insulin response.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):532-44. PubMed ID: 4346919
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin release from pancreatic islets of fetal rats mediated by leucine b-BCH, tolbutamide, glibenclamide, arginine, potassium chloride, and theophylline does not require stimulation of Ca2+ net uptake.
    Ammon HP; Glocker C; Waldner RG; Wahl MA
    Cell Calcium; 1989; 10(6):441-50. PubMed ID: 2505929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.
    Lambillotte C; Gilon P; Henquin JC
    J Clin Invest; 1997 Feb; 99(3):414-23. PubMed ID: 9022074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolbutamide-induced changes of the DNA, protein and insulin content and the secretory activity of isolated rat pancreatic islets.
    Schauder P; Frerichs H
    Diabetologia; 1975 Aug; 11(4):301-5. PubMed ID: 1107120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretion and cyclic adenosine 3', 5'-monophosphate levels in pancreatic islets of fed and fasted rats. Time course and dose kinetics during glucose stimulation.
    Bouman PR; Wolters GH; Konijnendijk W
    Diabetes; 1979 Feb; 28(2):132-40. PubMed ID: 217791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of cyclic AMP in the control of insulin secretion (author's transl)].
    Cerasi E; Grill V
    MMW Munch Med Wochenschr; 1977 Sep; 119(38):1229-36. PubMed ID: 198651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues.
    Panagiotidis G; Akesson B; Rydell EL; Lundquist I
    Br J Pharmacol; 1995 Jan; 114(2):289-96. PubMed ID: 7533613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cyclic AMP in the pathogenesis of glucose desensitization in rat pancreatic islets.
    Yoshikawa H; Tajiri Y; Sako Y; Hashimoto T; Umeda F; Nawata H
    Pancreas; 2001 May; 22(4):419-26. PubMed ID: 11345144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-induced alterations in insulin release in hamster islets of Langerhans.
    Rayfield EJ; Seto Y; Walsh S; McEvoy RC
    J Clin Invest; 1981 Nov; 68(5):1172-81. PubMed ID: 6271807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective early phase insulin release in perifused isolated pancreatic islets of spiny mice (Acomys cahirinus).
    Rabinovitch A; Gutzeit A; Kikuchi M; Cerasi E; Renold AE
    Diabetologia; 1975 Oct; 11(5):457-65. PubMed ID: 171800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of age on the insulin secretory response of perfused rat pancreas to arginine and tolbutamide.
    Curry DL; Safarik RH; Reaven E
    Horm Metab Res; 1987 Oct; 19(10):453-7. PubMed ID: 3323011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.